A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

NCT05473715 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated due to administrative reasons not related to efficacy or safety.

Conditions

Interventions

Sponsor

Bayer